Cerenion awarded first key patents on its brain monitoring technology
The European Intellectual Property Office (EUIPO) and the U.S. Patent and Trademark Office (USPTO) have separately awarded Cerenion Oy patents related to its novel measure of brain condition and function.
The patents, also accompanied by an awarded worldwide PCT-extension, cover key aspects of the Cerenion C-Trend® technology. The patents provide protection for the novel intellectual property behind the next-generation brain monitoring technology.
"These patents recognize the great value of our technology, and provide us with a solid foundation for moving towards product launch on the international marketplace", says Dr. Jukka Kortelainen, Chief Medical Officer and head of IPR Management at Cerenion.
Cerenion Oy has filed multiple intellectual property applications on its technology worldwide.
Highlights
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy Elektroniikkatie 3 90590 Oulu FINLAND
HELSINKI
Cerenion Oy Kyllikinportti 2 00240 Helsinki FINLAND